Multiple Sclerosis News Today

April 12, 2021April 12, 2021

US Survey Seeks to Understand Effects of MS on Patient Community

People living with multiple sclerosis (MS) and their caregivers are invited to help the patient and healthcare communities better understand MS by participating online in the 9th annual MS in ... Read more

April 12, 2021April 12, 2021

MS Has 3 Distinct Subtypes, Study of MRI Brain Patterns Using AI Reports

Multiple Sclerosis News Today

Using artificial intelligence (AI) on imaging data collected from multiple sclerosis (MS) patients, researchers were able to classify these people into three new disease subtypes, each distinct from the current ... Read more

April 9, 2021April 9, 2021

Retinal Layer Thickness May Predict MS Progression, Relapses

Multiple Sclerosis News Today

Measurements of the thickness of the eye’s retina — the layer of nerve cells lining the back of the eye — could be used to predict disability progression and relapses ... Read more

April 9, 2021April 9, 2021

Overall Cost of DMTs Stable 2018–2020, Study Finds

Multiple Sclerosis News Today

The overall cost of disease-modifying therapies for multiple sclerosis (MS) in the U.S. remained stable from 2018 to 2020, according to pharmacy and medical claims data from Prime Therapeutics’ insured ... Read more

April 8, 2021April 8, 2021

Mertk Gene Plays Key Role in Myelin Repair, Mouse Study Finds

Multiple Sclerosis News Today

A gene called Mertk has important roles in the repair of myelin, the fatty substance that surrounds and protects neurons and that is lost in multiple sclerosis (MS). The findings ... Read more

April 8, 2021April 8, 2021

Under-the-skin Injection of Tysabri Approved in Europe

Multiple Sclerosis News Today

The European Commission (EC) has approved a new method to administer Tysabri (natalizumab) as a treatment for people with relapsing-remitting multiple sclerosis (RRMS). This new delivery route involves a subcutaneous injection ... Read more

April 7, 2021April 7, 2021

Tecfidera, Gilenya and Ocrevus Losing Favor as Switch Therapies in US, Spherix Finds

COVID-19 News, Multiple Sclerosis News Today

Tecfidera (dimethyl fumarate), Gilenya (fingolimod), and Ocrevus (ocrelizumab) are losing ground to more recent therapies among U.S. multiple sclerosis (MS) patients switching treatment, according to the latest Spherix Global Insights’ report. The ... Read more

April 7, 2021April 7, 2021

Pediatric-onset MS Tied to Fewer School Years, Lower Income in Adulthood

Multiple Sclerosis News Today

People who develop multiple sclerosis (MS) as children are more likely to attain lower education levels, earn less in the workplace, and be more reliant on disability benefits later in ... Read more

April 6, 2021April 6, 2021

N-acetyl Cysteine Safe, But Failed to Lessen MS Fatigue

Multiple Sclerosis News Today

Treatment with the antioxidant N‐acetyl cysteine is well-tolerated, but failed to outperform a placebo at easing fatigue in people with progressive multiple sclerosis (MS), a small clinical trial found. More ... Read more

April 6, 2021April 6, 2021

Rates of MS Seem to Rise With Nations’ Prosperity

Multiple Sclerosis News Today

Rates of multiple sclerosis (MS) appear to rise with measures of prosperity, occurring more frequently in developed countries, according to a recent study. The reasons for such disparities may be ... Read more

April 5, 2021April 5, 2021

Reeve Foundation Launches Support Groups for People Affected by Paralysis

COVID-19 News, Multiple Sclerosis News Today

The Christopher & Dana Reeve Foundation has launched virtual support groups for people living with paralysis — either due to multiple sclerosis (MS) or other conditions — and their caregivers. ... Read more

April 5, 2021April 5, 2021

Switching From Gilenya to Lemtrada May Not Be Optimal Choice, Study Says

Multiple Sclerosis News Today

Previous treatment with oral Gilenya (fingolimod) is associated with a suboptimal response to Lemtrada (alemtuzumab) and an increased risk of secondary autoimmune disorders in multiple sclerosis (MS) patients, a study reports. ... Read more

April 2, 2021April 2, 2021

MS Run the US 3,260-mile Relay Keeps Going Despite Pandemic

COVID-19 News, Multiple Sclerosis News Today

The pandemic notwithstanding, MS Run the US has fielded 18 runners — including eight with multiple sclerosis (MS) — to traverse the United States to raise awareness and funds to ... Read more

April 2, 2021April 3, 2021

Protecting Myelin-producing Cells From Inflammation May Be Key to Treating MS

Multiple Sclerosis News Today

Prolonging a cellular defense mechanism shown to restore myelin — the protective sheath around nerve cell fibers that is lost in multiple sclerosis (MS) — may be key to treating ... Read more

April 1, 2021April 1, 2021

Wise Will Seek FDA Approval for Digital Anxiety Management Therapy

COVID-19 News, Multiple Sclerosis News Today

Wise Therapeutics intends to seek U.S. Food and Drug Administration (FDA) approval of an anxiety management therapy for multiple sclerosis (MS), following the positive results of a clinical trial. In ... Read more